Literature DB >> 20160165

Allo-HLA reactivity of virus-specific memory T cells is common.

Avital L Amir1, Lloyd J A D'Orsogna, Dave L Roelen, Marleen M van Loenen, Renate S Hagedoorn, Renate de Boer, Menno A W G van der Hoorn, Michel G D Kester, Ilias I N Doxiadis, J H Frederik Falkenburg, Frans H J Claas, Mirjam H M Heemskerk.   

Abstract

Graft-versus-host disease and graft rejection are major complications of allogeneic HLA-mismatched stem cell transplantation or organ transplantation that are caused by alloreactive T cells. Because a range of acute viral infections have been linked to initiating these complications, we hypothesized that the cross-reactive potential of virus-specific memory T cells to allogeneic (allo) HLA molecules may be able to mediate these complications. To analyze the allo-HLA reactivity, T cells specific for Epstein-Barr virus, cytomegalovirus, varicella zoster virus, and influenza virus were tested against a panel of HLA-typed target cells, and target cells transduced with single HLA molecules. Eighty percent of T-cell lines and 45% of virus-specific T-cell clones were shown to cross-react against allo-HLA molecules. The cross-reactivity of the CD8 and CD4 T-cell clones was directed primarily against HLA class I and II, respectively. However, a restricted number of CD8 T cells exhibited cross-reactivity to HLA class II. T-cell receptor (TCR) gene transfer confirmed that allo-HLA reactivity and virus specificity were mediated via the same TCR. These results demonstrate that a substantial proportion of virus-specific T cells exert allo-HLA reactivity, which may have important clinical implications in transplantation settings as well as adoptive transfer of third-party virus-specific T cells.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20160165     DOI: 10.1182/blood-2009-07-234906

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  118 in total

1.  Mixed T cell receptor dimers harbor potentially harmful neoreactivity.

Authors:  Marleen M van Loenen; Renate de Boer; Avital L Amir; Renate S Hagedoorn; Gerdien L Volbeda; Roelof Willemze; Johannes J van Rood; J H Frederik Falkenburg; Mirjam H M Heemskerk
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells.

Authors:  W H Kitchens; D Haridas; M E Wagener; M Song; A D Kirk; C P Larsen; M L Ford
Journal:  Am J Transplant       Date:  2011-09-22       Impact factor: 8.086

Review 3.  Transplantation tolerance through mixed chimerism.

Authors:  Nina Pilat; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2010-08-31       Impact factor: 28.314

4.  Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire.

Authors:  David A Ostrov; Barry J Grant; Yuri A Pompeu; John Sidney; Mikkel Harndahl; Scott Southwood; Carla Oseroff; Shun Lu; Jean Jakoncic; Cesar Augusto F de Oliveira; Lun Yang; Hu Mei; Leming Shi; Jeffrey Shabanowitz; A Michelle English; Amanda Wriston; Andrew Lucas; Elizabeth Phillips; Simon Mallal; Howard M Grey; Alessandro Sette; Donald F Hunt; Soren Buus; Bjoern Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

Review 5.  The Microbiome, Systemic Immune Function, and Allotransplantation.

Authors:  Anoma Nellore; Jay A Fishman
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

6.  Low-Affinity Memory CD8+ T Cells Mediate Robust Heterologous Immunity.

Authors:  Scott M Krummey; Ryan J Martinez; Rakieb Andargachew; Danya Liu; Maylene Wagener; Jacob E Kohlmeier; Brian D Evavold; Christian P Larsen; Mandy L Ford
Journal:  J Immunol       Date:  2016-02-10       Impact factor: 5.422

7.  A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

Authors:  Hiroki Torikai; Andreas Reik; Pei-Qi Liu; Yuanyue Zhou; Ling Zhang; Sourindra Maiti; Helen Huls; Jeffrey C Miller; Partow Kebriaei; Brian Rabinovich; Brian Rabinovitch; Dean A Lee; Richard E Champlin; Chiara Bonini; Luigi Naldini; Edward J Rebar; Philip D Gregory; Michael C Holmes; Laurence J N Cooper
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

8.  Depletion of naive T cells using clinical grade magnetic CD45RA beads: a new approach for GVHD prophylaxis.

Authors:  D Teschner; E Distler; D Wehler; M Frey; D Marandiuc; K Langeveld; M Theobald; S Thomas; W Herr
Journal:  Bone Marrow Transplant       Date:  2013-08-12       Impact factor: 5.483

9.  Kidney infection with HIV-1 following kidney transplantation.

Authors:  Peter G Stock
Journal:  J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 10.121

10.  Transplantation preferentially induces a KLRG-1lo CD127hi differentiation program in antigen-specific CD8+ T cells.

Authors:  Alana M Bozeman; Sonia J Laurie; Divya Haridas; Maylene E Wagener; Mandy L Ford
Journal:  Transpl Immunol       Date:  2018-06-08       Impact factor: 1.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.